Atlas Trials

Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.

Clinical trial NCT03744585 · COMPLETED

Trial details

NCT number
NCT03744585
Sponsor
Ipsen
Status
COMPLETED
Study type
OBSERVATIONAL
Renal Cell Carcinoma
Start date
2018-11-06
Primary completion
2019-06-07
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.